港股詳情

本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

科倫博泰生物-B

285.400

-3.600-1.25%

成交量：81.19萬

成交額：2.33億

市值：647.86億

市盈率：-222.81

高：294.000

開：285.000

低：275.000

收：289.000

資料載入中...

總覽公司新聞公告

科倫博泰(06990.HK)抗PD-L1塔戈利單抗獲國家藥監局批准上市

阿斯达克财经

科倫博泰生物塔戈利單抗獲批上市

【科倫博泰生物-B(06990.HK)：抗PD-L1塔戈利單抗獲國家藥監局批准上市】科倫博泰生物-B(06990.HK)發佈公告，公司用於治療既往接受過2線及以上化療失敗的復發或轉移性鼻咽癌患者的靶向程序性細胞死亡配體1(PD-L1)的創新人源化單克隆抗體(單抗)塔戈利單抗(前稱KL-A167)(科泰萊®)已獲中國國家藥品監督管理局(NMPA)批准於中國上市。

科倫博泰生物-B：抗PD-L1塔戈利單抗獲國家藥品監督管理局批准上市

格隆汇资讯

科倫博泰生物-B12月31日遭主力拋售590萬元環比增加177.00%

國信證券: 持續推薦創新藥械關注醫療設備投資機會

科倫博泰生物-B12月24日獲主力加倉120萬元環比增加361.54%

科倫博泰生物-B12月20日主力資金流出61萬元連續3日減倉

科倫博泰生物-B12月19日遭主力拋售303萬元環比增加422.41%

科倫博泰生物完成新內資股認購，總股本增至2.27億股

科倫博泰生物-B(06990)完成根據特別授權認購442.39萬股新內資股

金十數據整理：每日港股市場要聞速遞（12月18 日週三）

科倫博泰生物-B12月17日認購3億元理財產品

科倫博泰生物-B(06990)向興業銀行認購合計3億元的結構性存款

《大行》摩通首予科倫博泰生物(06990.HK)“增持”評級目標價240元

阿斯达克财经

醫藥股多數承壓來凱醫藥(02105)跌近11% 機構指板塊當前已經處於業績、政策和資金三重反轉的進程中

科倫博泰生物-B(06990)下跌5.06%，報178.1元/股

科倫博泰生物-B盤中異動股價大跌5.06%報178.100港元

【券商聚焦】浦銀國際對2025年醫藥板塊整體呈樂觀態度看好創新藥、醫療器械及CXO

國金證券：醫藥政策暖風先到關注創新藥和仿創藥的板塊高景氣度投資機會

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/hant/stock/06990/news?page=8"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"06990","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06990\",,,,,undefined,":{"symbol":"06990","market":"HK","secType":"STK","nameCN":"科倫博泰生物-B","latestPrice":285.4,"timestamp":1744877289037,"preClose":289,"halted":0,"volume":811904,"delay":0,"floatShares":131000000,"shares":227000000,"eps":-1.2808888846834403,"marketStatus":"未開盤","change":-3.6,"latestTime":"04-17 16:08:09","open":285,"high":294,"low":275,"amount":232778521,"amplitude":0.065744,"askPrice":286.4,"askSize":300,"bidPrice":285.4,"bidSize":300,"shortable":3,"etf":0,"ttmEps":-1.2808888846834403,"tradingStatus":0,"nextMarketStatus":{"tag":"開盤","tradingStatus":2,"beginTime":1745285400000},"marketStatusCode":0,"adr":0,"listingDate":1689004800000,"exchange":"SEHK","adjPreClose":289,"openAndCloseTimeList":[[1744853400000,1744862400000],[1744866000000,1744876800000]],"volumeRatio":1.0355934219983844,"lotSize":100,"spreadScale":0,"tradeCurrency":"HKD"},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"06990\",,,,,undefined,":{"symbol":"06990","floatShares":131000000,"roa":"-3.41%","roe":"-9.46%","lyrEps":-1.280889,"volumeRatio":1.0355934219983844,"shares":227000000,"dividePrice":0,"high":294,"amplitude":0.065744,"preClose":289,"low":275,"week52Low":120.2,"pbRate":"18.40","psRate":"31.49","week52High":346,"institutionHeld":0,"latestPrice":285.4,"eps":-1.2808888846834403,"divideRate":0,"volume":811904,"delay":0,"ttmEps":-1.2808888846834403,"open":285,"prevYearClose":163.3,"prevWeekClose":285.4,"prevMonthClose":290.8,"prevQuarterClose":290.8,"fiveDayClose":280.8,"twentyDayClose":259.4,"sixtyDayClose":162.6},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"06990\",pageSize:20,pageCount:8,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2495182616","title":"科倫博泰(06990.HK)抗PD-L1塔戈利單抗獲國家藥監局批准上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2495182616","media":"阿斯达克财经","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495182616?lang=zh_tw&edition=fundamental","pubTime":"2024-12-31 22:04","pubTimestamp":1735653840,"startTime":"0","endTime":"0","summary":"科伦博泰生物－Ｂ(06990.HK) 公布，公司用于治疗既往接受过2线及以上化疗失败的复发或转移性鼻咽癌患者的靶向程序性细胞死亡配体1(PD-L1)创新人源化单克隆抗体塔戈利单抗(科泰莱)已获中国国家药品监督管理局批准上市。(de/d)(港股报价延迟最少十五分钟。沽空资料截至 2024-12-31 12:25。)AASTOCKS新闻","market":"fut","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20220210100852532_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20220210100852532_s.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/news/aafn-con/NOW.1407173/latest-news/AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["LU0196878994.USD","BK1161","06990"],"gpt_icon":0},{"id":"2495989316","title":"科倫博泰生物塔戈利單抗獲批上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2495989316","media":"财中社","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495989316?lang=zh_tw&edition=fundamental","pubTime":"2024-12-31 18:28","pubTimestamp":1735640915,"startTime":"0","endTime":"0","summary":"财中社12月31日电科伦博泰生物-B（06990）发布公告，宣布其用于治疗既往接受过2线及以上化疗失败的复发或转移性鼻咽癌患者的靶向单抗塔戈利单抗（前称KL-A167，科泰莱?）已获得中国国家药品监督管理局批准上市。此次获批主要基于一项在132例患者中进行的II期临床研究，评估塔戈利单抗的有效性和安全性。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202412313284181760.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0196878994.USD","BK1161","06990","OS","BK4097"],"gpt_icon":0},{"id":"2495664072","title":"【科倫博泰生物-B(06990.HK)：抗PD-L1塔戈利單抗獲國家藥監局批准上市】科倫博泰生物-B(06990.HK)發佈公告，公司用於治療既往接受過2線及以上化療失敗的復發或轉移性鼻咽癌患者的靶向程序性細胞死亡配體1(PD-L1)的創新人源化單克隆抗體(單抗)塔戈利單抗(前稱KL-A167)(科泰萊®)已獲中國國家藥品監督管理局(NMPA)批准於中國上市。","url":"https://stock-news.laohu8.com/highlight/detail?id=2495664072","media":"金融界","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495664072?lang=zh_tw&edition=fundamental","pubTime":"2024-12-31 18:06","pubTimestamp":1735639600,"startTime":"0","endTime":"0","summary":"科伦博泰生物-B(06990.HK)发布公告，公司用于治疗既往接受过2线及以上化疗失败的复发或转移性鼻咽癌患者的靶向程序性细胞死亡配体1(PD-L1)的创新人源化单克隆抗体(单抗)塔戈利单抗(前称KL-A167)(科泰莱®)已获中国国家药品监督管理局(NMPA)批准于中国上市。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://24h.jrj.com.cn/2024/12/31180646994450.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["LU0196878994.USD","LU1169589451.USD","06990","PD","BK1161","LU1169590202.USD","BK4023"],"gpt_icon":0},{"id":"2495664287","title":"科倫博泰生物-B：抗PD-L1塔戈利單抗獲國家藥品監督管理局批准上市","url":"https://stock-news.laohu8.com/highlight/detail?id=2495664287","media":"格隆汇资讯","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495664287?lang=zh_tw&edition=fundamental","pubTime":"2024-12-31 17:58","pubTimestamp":1735639090,"startTime":"0","endTime":"0","summary":"格隆汇12月31日丨科伦博泰生物-B发布公告，公司用于治疗既往接受过2线及以上化疗失败的复发或转移性鼻咽癌患者的靶向程序性细胞死亡配体1的创新人源化单克隆抗体塔戈利单抗（科泰莱）已获中国国家药品监督管理局批准于中国上市。同时，塔戈利单抗具有可管理的安全性，3级免疫相关不良事件为3.9%，未观察到3级以上免疫相关不良事件。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231175820985647d7&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231175820985647d7&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU0196878994.USD","06990"],"gpt_icon":0},{"id":"2495668691","title":"科倫博泰生物-B12月31日遭主力拋售590萬元 環比增加177.00%","url":"https://stock-news.laohu8.com/highlight/detail?id=2495668691","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2495668691?lang=zh_tw&edition=fundamental","pubTime":"2024-12-31 16:17","pubTimestamp":1735633022,"startTime":"0","endTime":"0","summary":"12月31日, 科伦博泰生物-B股价跌3.26%，报收163.30元，成交金额6885万元，换手率0.32%，振幅4.50%，量比1.39。科伦博泰生物-B今日主力资金净流出590万元，连续3日净流出，上一交易日主力净流出213万元，今日环比增加177.00%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为83.33%，平均跌幅为3.08%。该股近5个交易日下跌8.57%，主力资金累计净流出1232万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流出1897万元，其中净流出天数为13日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231161757a210235f&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241231161757a210235f&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU0196878994.USD","06990"],"gpt_icon":0},{"id":"2494821898","title":"國信證券: 持續推薦創新藥械 關注醫療設備投資機會","url":"https://stock-news.laohu8.com/highlight/detail?id=2494821898","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494821898?lang=zh_tw&edition=fundamental","pubTime":"2024-12-27 13:56","pubTimestamp":1735278995,"startTime":"0","endTime":"0","summary":"智通财经APP获悉，国信证券发布研报称，国内医疗需求持续升级，宏观经济有望逐步回暖。目前，行业正经历较为剧烈的供给侧结构性改革，药品及器械集采亦接近尾声，25年有望进入新一轮增长周期。在地缘政治扰动之下，国家有望加大对于自主可控的支持力度，建议优先配置创新药、创新器械、医疗设备等细分行业，同时建议关注AI医疗、并购重组等带来的主题投资机会。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1229930.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["BK0188","00013","IE00B5MMRT66.SGD","399265","BK1588","09926","BK1574","BK1161","LU0348784397.USD","BK1587","002736","BK0028","159873","LU1794554557.SGD","IE00BPRC5H50.USD","LU0417516571.SGD","BK0183","BK0276","LU0348783233.USD","BK1191","IE00B543WZ88.USD","LU0196878994.USD","LU1720050803.USD","06990","LU2488822045.USD"],"gpt_icon":0},{"id":"2493774023","title":"科倫博泰生物-B12月24日獲主力加倉120萬元 環比增加361.54%","url":"https://stock-news.laohu8.com/highlight/detail?id=2493774023","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493774023?lang=zh_tw&edition=fundamental","pubTime":"2024-12-24 16:16","pubTimestamp":1735028208,"startTime":"0","endTime":"0","summary":"12月24日, 科伦博泰生物-B股价跌0.75%，报收171.20元，成交金额3605万元，换手率0.16%，振幅3.42%，量比0.86。科伦博泰生物-B今日主力资金净流入120万元，上一交易日主力净流入26万元，今日环比增加361.54%。该股近5个交易日下跌3.60%，主力资金累计净流出276万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入940万元，其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224161758a2070f7d&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241224161758a2070f7d&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06990","BK1161","LU0196878994.USD"],"gpt_icon":0},{"id":"2492959094","title":"科倫博泰生物-B12月20日主力資金流出61萬元 連續3日減倉","url":"https://stock-news.laohu8.com/highlight/detail?id=2492959094","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492959094?lang=zh_tw&edition=fundamental","pubTime":"2024-12-20 16:16","pubTimestamp":1734682609,"startTime":"0","endTime":"0","summary":"12月20日, 科伦博泰生物-B股价涨2.53%，报收178.60元，成交金额4850万元，换手率0.21%，振幅3.67%，量比1.01。科伦博泰生物-B今日主力资金净流出61万元，连续3日净流出，上一交易日主力净流出303万元，今日环比减少79.87%。近一年数据显示，该股主力连续3日净流出后，次日下跌概率为54.55%，平均跌幅为3.14%。该股近5个交易日下跌4.37%，主力资金累计净流出136万元，其中1个交易日为股价上涨时净流出；近20日主力资金累计净流入2089万元，其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220162000a1fd2968&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241220162000a1fd2968&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06990","BK1161","LU0196878994.USD"],"gpt_icon":0},{"id":"2492142555","title":"科倫博泰生物-B12月19日遭主力拋售303萬元 環比增加422.41%","url":"https://stock-news.laohu8.com/highlight/detail?id=2492142555","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492142555?lang=zh_tw&edition=fundamental","pubTime":"2024-12-19 16:16","pubTimestamp":1734596168,"startTime":"0","endTime":"0","summary":"12月19日, 科伦博泰生物-B股价跌0.63%，报收174.20元，成交金额6847万元，换手率0.30%，振幅3.99%，量比1.77。科伦博泰生物-B今日主力资金净流出303万元，上一交易日主力净流出58万元，今日环比增加422.41%。该股近5个交易日下跌7.89%，主力资金累计净流出138万元；近20日主力资金累计净流入1958万元，其中净流入天数为8日。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219162709ab83f00b&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241219162709ab83f00b&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU0196878994.USD","06990"],"gpt_icon":0},{"id":"2492909838","title":"科倫博泰生物完成新內資股認購，總股本增至2.27億股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492909838","media":"财中社","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492909838?lang=zh_tw&edition=fundamental","pubTime":"2024-12-18 18:37","pubTimestamp":1734518250,"startTime":"0","endTime":"0","summary":"财中社12月18日电科伦博泰生物-B（06990）发布公告，宣布已完成根据特别授权认购新内资股的事项。根据公告，认购事项的所有条件已获达成，已接获中国证券登记结算有限责任公司出具的股份登记证明，确认442万股新内资股已入账，向认购人发行。此次完成后，公司股份总数增加至2.27亿股。公告中还披露了公司股权结构的变动情况。认购事项完成前后，主要股东的股份比例有所调整。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202412183272208521.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["LU0196878994.USD","06990","BK1161"],"gpt_icon":0},{"id":"2492031369","title":"科倫博泰生物-B(06990)完成根據特別授權認購442.39萬股新內資股","url":"https://stock-news.laohu8.com/highlight/detail?id=2492031369","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492031369?lang=zh_tw&edition=fundamental","pubTime":"2024-12-18 18:10","pubTimestamp":1734516630,"startTime":"0","endTime":"0","summary":"智通财经APP讯，科伦博泰生物-B(06990)发布公告，认购事项的所有条件已获达成，且公司已接获中国证券登记结算有限责任公司出具日期为2024年12月17日的有关根据认购事项发行的新内资股股份登记证明。认购事项已完成。根据认购协议，442.39万股新内资股已入账列作缴足及向认购人发行。因此，紧随认购事项完成后，公司的股份总数为2.27亿股。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1226588.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["LU0196878994.USD","BK1161","06990"],"gpt_icon":0},{"id":"2492943062","title":"金十數據整理：每日港股市場要聞速遞（12月18 日 週三）","url":"https://stock-news.laohu8.com/highlight/detail?id=2492943062","media":"美港电讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492943062?lang=zh_tw&edition=fundamental","pubTime":"2024-12-18 09:01","pubTimestamp":1734483698,"startTime":"0","endTime":"0","summary":null,"market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.ushknews.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_meigang","symbols":["UBmain","BK1240","01378","01898","HSTECH","LU1781817850.SGD","BK1501","601166","BK1594","LU1997245094.SGD","LU1048596156.SGD","01398","01907","01456","09983","ZBmain","BK1229","161027","BK1542","03908","BK1560","BK1516","601898","SG9999001093.SGD","601995","06990","03143","601398","161123","07226","YANG","601456","ZFmain","BK0179","BK1161","06818","ZTmain","BK1538","TNmain","HSCEI","03347","BK0006","LU0359201612.USD","02777","03692","ZNmain","BK1191","LU0702159699.USD"],"gpt_icon":0},{"id":"2492696129","title":"科倫博泰生物-B12月17日認購3億元理財產品","url":"https://stock-news.laohu8.com/highlight/detail?id=2492696129","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492696129?lang=zh_tw&edition=fundamental","pubTime":"2024-12-17 23:27","pubTimestamp":1734449221,"startTime":"0","endTime":"0","summary":"格隆汇12月17日丨科伦博泰生物-B(06990.HK)公告，于2024年12月17日，公司订立兴业银行结构性存款协议I和兴业银行结构性存款协议II，据此，公司同意向兴业银行认购两笔本金额分别为人民币1.7亿元和人民币1.3亿元的结构性存款。于本公告日期，存置于兴业银行的理财产品未偿还本金总额为人民币4.2亿元。【免责声明】本文仅代表作者本人观点，与和讯网无关。和讯网站对文中陈述、观点判断保持中立，不对所包含内容的准确性、可靠性或完整性提供任何明示或暗示的保证。请读者仅作参考，并请自行承担全部责任。邮箱：news_center@staff.hexun.com","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217233229a1f626d1&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241217233229a1f626d1&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["06990","BK1161","LU0196878994.USD"],"gpt_icon":0},{"id":"2492950966","title":"科倫博泰生物-B(06990)向興業銀行認購合計3億元的結構性存款","url":"https://stock-news.laohu8.com/highlight/detail?id=2492950966","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492950966?lang=zh_tw&edition=fundamental","pubTime":"2024-12-17 23:00","pubTimestamp":1734447620,"startTime":"0","endTime":"0","summary":"于本公告日期，存置于兴业银行的理财产品未偿还本金总额为人民币4.2亿元。于2024年12月17日，公司订立中信银行结构性存款协议II，公司同意向中信银行认购本金额为人民币1亿元的结构性存款。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1226245.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06990","LU1580142542.USD","BK0278","LU0821914370.USD","601166","LU0196878994.USD","BK0187","LU0572939691.SGD","BK0188","BK0012","LU1781817850.SGD","BK0015","BK0183","BK0028","LU0264606111.USD","LU1048596156.SGD","BK1161","LU1328615791.USD","LU0572940350.SGD"],"gpt_icon":0},{"id":"2492608538","title":"《大行》摩通首予科倫博泰生物(06990.HK)“增持”評級  目標價240元","url":"https://stock-news.laohu8.com/highlight/detail?id=2492608538","media":"阿斯达克财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492608538?lang=zh_tw&edition=fundamental","pubTime":"2024-12-17 10:02","pubTimestamp":1734400920,"startTime":"0","endTime":"0","summary":"摩根大通发表研究报告指，首予科伦博泰生物-B“增持”评级，目标价240元。科伦博泰生物成立于2016年，目前，其在中国市场拥有一款抗体药物偶联物 SKB264，并且有八个ADC正在进行临床测试中，另有三个非ADC癌症药物正在中国的新药申请审批之中。因此，该行估计SKB264在中国的潜在销售高峰或逾80亿元人民币，而在中国以外的销售高峰可达到60亿美元。","market":"hk","thumbnail":"https://plib.aastocks.com/aafnnews/image/medialib/20230904161537733_s.jpg","type":0,"news_type":0,"thumbnails":["https://plib.aastocks.com/aafnnews/image/medialib/20230904161537733_s.jpg"],"rights":null,"property":["rate"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.aastocks.com/tc/stocks/analysis/china-hot-topic-content.aspx?id=NOW.1404595&catg=4&source=AAFN","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"aastocks_highlight","symbols":["06990"],"gpt_icon":0},{"id":"2491630509","title":"醫藥股多數承壓 來凱醫藥(02105)跌近11% 機構指板塊當前已經處於業績、政策和資金三重反轉的進程中","url":"https://stock-news.laohu8.com/highlight/detail?id=2491630509","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491630509?lang=zh_tw&edition=fundamental","pubTime":"2024-12-16 14:56","pubTimestamp":1734332198,"startTime":"0","endTime":"0","summary":"金吾财讯 | 医药股多数承压，来凯医药 跌10.94%，康诺亚跌6.07%，金斯瑞生物科技跌5.54%，科伦博泰生物跌4.96%，康方生物跌4.4%，药明生物跌3.15%。国金证券发研指，医药板块当前已经处于业绩、政策和资金三重反转的进程之中，对2025年医药板块上市公司营收利润增速回升、板块行情复苏有充分信心。医保局将指导各地及中选企业做好中选结果落地实施工作，确保全国患者于2025年4月用上本次集采中选产品。","market":"nz","thumbnail":"https://static.szfiu.com/news/20210810/ZTUyNTQ0NjcxODUwNQ==.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/ZTUyNTQ0NjcxODUwNQ==.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1949709","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320764599.SGD","LU0348784397.USD","LU0043850808.USD","LU0456827905.SGD","LU0516423091.SGD","02269","LU1242518857.USD","LU0516423174.USD","BK1583","BK1576","IE00B5MMRT66.SGD","LU0307460666.USD","LU0823426308.USD","LU0516422952.EUR","BK1574","LU0823426480.USD","LU2039709279.SGD","02105","09939","LU0588546209.SGD","LU0348825331.USD","LU0140636845.USD","LU0051755006.USD","LU0359201612.USD","BK1521","LU0417516571.SGD","LU0359202008.SGD","BK1587","LU0181495838.USD","LU0572944931.SGD","LU0456846285.SGD","09926","06990","LU0348735423.USD","LU0348783233.USD","LU0516422366.SGD","LU2488822045.USD","HK0000306685.HKD","159938","LU1880383366.USD","LU1242518931.SGD","01548","LU0326950275.SGD","HK0000320223.HKD","SG9999002463.SGD","HK0000306701.USD","IE00B0JY6N72.USD","LU1720050803.USD","LU0979878070.USD","02162"],"gpt_icon":1},{"id":"2491681760","title":"科倫博泰生物-B(06990)下跌5.06%，報178.1元/股","url":"https://stock-news.laohu8.com/highlight/detail?id=2491681760","media":"金融界","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491681760?lang=zh_tw&edition=fundamental","pubTime":"2024-12-16 09:59","pubTimestamp":1734314350,"startTime":"0","endTime":"0","summary":"12月16日，科伦博泰生物-B(06990)盘中下跌5.06%，截至09:59，报178.1元/股，成交675.62万元。四川科伦博泰生物医药股份有限公司是一家专注于创新药物研发、制造及商业化的生物医药公司，主要以抗体药物偶联物（ADC）的技术平台为基础，致力于解决全球普遍或难以治疗的癌症以及众多患人医疗需求未满足的其他疾病。公司拥有完善的一体化药物开发机制，已建立包含研发、生产、质量控制及商业化等全面功能的一体化能力，并有30多款差异化且具有临床价值的资产管线，其中10余款处于临床阶段。截至2024年中报，科伦博泰生物-B营业总收入13.83亿元、净利润3.1亿元。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://hk.jrj.com.cn/2024/12/16095946408465.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"jinrongjie_stock","symbols":["BK1161","06990","LU0196878994.USD"],"gpt_icon":0},{"id":"2491818196","title":"科倫博泰生物-B盤中異動 股價大跌5.06%報178.100港元","url":"https://stock-news.laohu8.com/highlight/detail?id=2491818196","media":"市场透视","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2491818196?lang=zh_tw&edition=fundamental","pubTime":"2024-12-16 09:59","pubTimestamp":1734314346,"startTime":"0","endTime":"0","summary":"2024年12月16日早盘09时59分，科伦博泰生物-B股票出现异动，股价快速下跌5.06%。截至发稿，该股报178.100港元/股，成交量3.73万股，换手率0.03%，振幅4.90%。资金方面，该股资金流入189.058万港元，流出446.681万港元。科伦博泰生物-B股票所在的生物技术行业中，整体跌幅为0.64%。科伦博泰生物-B公司简介：四川科伦博泰生物医药股份有限公司是一家主要从事创新药业务的研发、生产和销售的中国公司。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121609590695e9f880&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN2024121609590695e9f880&s=b","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tencent","symbols":["BK1161","LU0196878994.USD","06990"],"gpt_icon":0},{"id":"2490879827","title":"【券商聚焦】浦銀國際對2025年醫藥板塊整體呈樂觀態度 看好創新藥、醫療器械及CXO","url":"https://stock-news.laohu8.com/highlight/detail?id=2490879827","media":"金吾财讯","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490879827?lang=zh_tw&edition=fundamental","pubTime":"2024-12-12 15:52","pubTimestamp":1733989962,"startTime":"0","endTime":"0","summary":"2)医疗器械：看好创新高值耗材、医疗设备板块。康诺亚核心产品CM310将于2025年迎来首个完整年度商业化，作为首个国产重磅IL4R，该行认为其市场潜力巨大。此外，康诺亚研发实力强劲，NewCo形式有助于加快其出海步伐，2025年潜在出海交易有望进一步提振股票行情。","market":"us","thumbnail":"https://static.szfiu.com/news/20210810/NGI5ZWE4NDg5Y2ExYTk3MGU2NzMxODA4MzkxNTM=.jpg","type":0,"news_type":0,"thumbnails":["https://static.szfiu.com/news/20210810/NGI5ZWE4NDg5Y2ExYTk3MGU2NzMxODA4MzkxNTM=.jpg"],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"1949533","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823426308.USD","BK1589","BK1141","09939","BK1100","06160","02359","159992","LU2328871848.SGD","02269","00013","LU2125910500.SGD","LU0348784397.USD","LU2045819591.USD","LU1720050803.USD","LU0181495838.USD","BK1610","01789","BK1191","02190","LU0043850808.USD","LU0516422366.SGD","LU0359202008.SGD","09926","IE00B5MMRT66.SGD","IE00B543WZ88.USD","09996","LU2488822045.USD","LU0979878070.USD","LU0327786744.USD","LU0348735423.USD","LU0572944931.SGD","CXO","02162","02268","SG9999014674.SGD","03759","159883","06990","LU0196878994.USD","SG9999002463.SGD","LU0856984785.SGD","LU0307460666.USD","159938","LU0417516738.SGD","06978","LU0819121731.USD","SG9999002562.SGD","BK1521","09997"],"gpt_icon":1},{"id":"2490710267","title":"國金證券：醫藥政策暖風先到 關注創新藥和仿創藥的板塊高景氣度投資機會","url":"https://stock-news.laohu8.com/highlight/detail?id=2490710267","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490710267?lang=zh_tw&edition=fundamental","pubTime":"2024-12-09 16:14","pubTimestamp":1733732057,"startTime":"0","endTime":"0","summary":"2024年医药承压持续探底，但长期需求稳定，且政策、资金、基本面都存在反转趋势，2025年医药赛道有望取得超额收益，医药板块核心投资机会将围绕三大逻辑：1)创新出海；2)需求复苏；3)政策预期反转，关注创新药和仿创药的板块高景气度投资机会。投资建议2025年医药板块最大投资机会将围绕于两条主线：创新药和仿创药的板块高景气度投资机会；以及器械、中药、药店、消费医疗服务等领域的个股见底反弹投资机会。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://www.zhitongcaijing.com/content/detail/1222104.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_zhitongcaijing","symbols":["06978","BK0012","BK0183","BK0188","BK1161","09939","LU0196878994.USD","BK0276","159938","BK0028","BK0201","06990","600109","159992","BK1515","BK1574"],"gpt_icon":0}],"pageSize":20,"totalPage":10,"pageCount":8,"totalSize":200,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/06990\",params:#limit:5,,,undefined,":[{"date":"2025-03-24","symbol":"06990","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1742779800000,"name":null,"time":"盤後","dateTimestamp":1742745600000,"actualEps":null},{"date":"2024-08-19","symbol":"06990","type":"earning","reportTimeType":"post","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1724031000000,"name":null,"time":"盤後","dateTimestamp":1723996800000,"actualEps":null},{"date":"2024-03-25","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1711330200000,"name":null,"time":"","dateTimestamp":1711296000000,"actualEps":null},{"date":"2023-08-28","symbol":"06990","type":"earning","reportTimeType":"","market":"HK","fiscalQuarterEnding":null,"expectedEps":null,"defaultRemindTime":1693186200000,"name":null,"time":"","dateTimestamp":1693152000000,"actualEps":null}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"06990\",market:\"HK\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"06990\",market:\"HK\",delay:false,,,undefined,":{"strongBuy":0.2941,"buy":0.7059,"hold":0,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.7059,"analysts":17,"updateTime":1744646400000},"@#url:\"https://hq.skytigris.cn/hkstock/value_analysis/stock/06990\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"06990","date":"2025-04-17","current":-228.611836,"percent":0.03653,"low":-257.850518,"twenty":-159.44307,"median":-68.80487,"eighty":-45.06217,"high":-21.029201,"avg":-97.473315,"sd":62.021902,"marketCap":64862287200},"quantilePoints":[{"date":"2023-07-14","current":-21.13661,"twenty":-21.950454,"median":-21.915957,"eighty":-21.591449,"marketCap":14244687534},{"date":"2023-07-21","current":-23.970152,"twenty":-21.950454,"median":-21.798359,"eighty":-21.186829,"marketCap":16079230625},{"date":"2023-07-28","current":-25.171471,"twenty":-24.928642,"median":-21.953758,"eighty":-21.326081,"marketCap":16867005011},{"date":"2023-08-04","current":-23.795235,"twenty":-24.81024,"median":-23.425444,"eighty":-21.637654,"marketCap":15971316326},{"date":"2023-08-11","current":-25.354634,"twenty":-24.81024,"median":-23.323535,"eighty":-21.856149,"marketCap":16921892522},{"date":"2023-08-18","current":-27.290696,"twenty":-25.136334,"median":-23.811022,"eighty":-21.920213,"marketCap":18083628667},{"date":"2023-08-25","current":-27.955027,"twenty":-25.91111,"median":-24.066367,"eighty":-21.957062,"marketCap":18532979440},{"date":"2023-09-01","current":-41.23344,"twenty":-27.36684,"median":-24.766756,"eighty":-21.989236,"marketCap":16768455673},{"date":"2023-09-08","current":-41.179226,"twenty":-40.625811,"median":-24.994187,"eighty":-22.159386,"marketCap":16549260174},{"date":"2023-09-15","current":-42.756679,"twenty":-41.200358,"median":-25.354634,"eighty":-22.761005,"marketCap":17316444421},{"date":"2023-09-22","current":-42.808543,"twenty":-42.12743,"median":-25.915972,"eighty":-23.169807,"marketCap":17261645546},{"date":"2023-09-29","current":-41.568511,"twenty":-42.347449,"median":-27.197776,"eighty":-23.343916,"marketCap":16790375223},{"date":"2023-10-06","current":-41.914184,"twenty":-42.346401,"median":-27.481057,"eighty":-23.57336,"marketCap":16921892522},{"date":"2023-10-13","current":-45.021843,"twenty":-42.393899,"median":-34.166325,"eighty":-23.80155,"marketCap":18149387317},{"date":"2023-10-20","current":-39.509362,"twenty":-42.529229,"median":-40.304828,"eighty":-23.874674,"marketCap":15902633452},{"date":"2023-10-27","current":-41.923505,"twenty":-42.45246,"median":-40.317099,"eighty":-23.977981,"marketCap":16867093648},{"date":"2023-11-03","current":-44.17615,"twenty":-43.157759,"median":-40.968576,"eighty":-24.032126,"marketCap":17820594068},{"date":"2023-11-10","current":-48.451746,"twenty":-43.729096,"median":-41.213927,"eighty":-24.147781,"marketCap":19541278735},{"date":"2023-11-17","current":-48.422639,"twenty":-44.163404,"median":-41.246315,"eighty":-24.349478,"marketCap":19705675360},{"date":"2023-11-24","current":-47.973827,"twenty":-44.628759,"median":-41.529173,"eighty":-24.780872,"marketCap":19683755810},{"date":"2023-12-01","current":-50.941262,"twenty":-45.174782,"median":-41.90853,"eighty":-24.844962,"marketCap":20987969029},{"date":"2023-12-08","current":-50.880899,"twenty":-46.685504,"median":-41.9817,"eighty":-24.922954,"marketCap":20878371279},{"date":"2023-12-15","current":-53.058458,"twenty":-47.438439,"median":-42.172758,"eighty":-25.124621,"marketCap":21897630350},{"date":"2023-12-22","current":-55.272951,"twenty":-48.26932,"median":-42.355666,"eighty":-25.208104,"marketCap":22796331896},{"date":"2023-12-29","current":-54.398289,"twenty":-48.483234,"median":-42.389893,"eighty":-25.318001,"marketCap":22555216847},{"date":"2024-01-05","current":-54.305497,"twenty":-48.692055,"median":-42.518207,"eighty":-25.505631,"marketCap":22357940898},{"date":"2024-01-12","current":-58.852865,"twenty":-49.706536,"median":-42.808543,"eighty":-25.777515,"marketCap":24243022189},{"date":"2024-01-19","current":-48.649703,"twenty":-50.614438,"median":-43.44751,"eighty":-25.920835,"marketCap":20012549058},{"date":"2024-01-26","current":-45.202208,"twenty":-50.432693,"median":-43.523908,"eighty":-26.320623,"marketCap":18522019665},{"date":"2024-02-02","current":-38.832469,"twenty":-50.323187,"median":-43.65215,"eighty":-26.948338,"marketCap":15891673677},{"date":"2024-02-09","current":-43.972121,"twenty":-49.706536,"median":-43.780393,"eighty":-27.253528,"marketCap":18083628667},{"date":"2024-02-16","current":-51.156498,"twenty":-50.095577,"median":-43.99523,"eighty":-27.328768,"marketCap":21042767904},{"date":"2024-02-23","current":-57.052501,"twenty":-50.855188,"median":-44.095348,"eighty":-27.575851,"marketCap":23344320643},{"date":"2024-03-01","current":-55.517903,"twenty":-51.144997,"median":-44.174132,"eighty":-27.979787,"marketCap":22730573246},{"date":"2024-03-08","current":-62.556972,"twenty":-52.587613,"median":-44.308071,"eighty":-30.229554,"marketCap":25623953833},{"date":"2024-03-15","current":-80.340969,"twenty":-54.14227,"median":-44.794506,"eighty":-38.844663,"marketCap":32879324850},{"date":"2024-03-22","current":-87.812662,"twenty":-54.39157,"median":-45.089055,"eighty":-38.957109,"marketCap":35904222736},{"date":"2024-03-28","current":-54.646477,"twenty":-54.498503,"median":-45.202208,"eighty":-39.211798,"marketCap":33975302345},{"date":"2024-04-05","current":-48.790889,"twenty":-54.557693,"median":-45.399289,"eighty":-39.390336,"marketCap":30314737511},{"date":"2024-04-12","current":-51.407626,"twenty":-54.48688,"median":-46.006494,"eighty":-39.95604,"marketCap":31958703754},{"date":"2024-04-19","current":-48.134373,"twenty":-54.430626,"median":-46.386128,"eighty":-40.284427,"marketCap":29898266063},{"date":"2024-04-26","current":-71.709655,"twenty":-54.881886,"median":-46.751052,"eighty":-40.312191,"marketCap":36824843832},{"date":"2024-05-03","current":-70.050704,"twenty":-55.277405,"median":-46.894686,"eighty":-40.440284,"marketCap":35948061836},{"date":"2024-05-10","current":-80.537958,"twenty":-55.535893,"median":-47.299854,"eighty":-40.706984,"marketCap":41427949311},{"date":"2024-05-17","current":-72.846762,"twenty":-56.640749,"median":-47.434905,"eighty":-40.885351,"marketCap":37416671679},{"date":"2024-05-24","current":-76.490072,"twenty":-57.838988,"median":-47.480121,"eighty":-41.121673,"marketCap":39198277014},{"date":"2024-05-31","current":-74.804992,"twenty":-59.45269,"median":-48.0541,"eighty":-41.186166,"marketCap":38373753847},{"date":"2024-06-07","current":-77.551054,"twenty":-62.567703,"median":-48.422639,"eighty":-41.217553,"marketCap":39733102851},{"date":"2024-06-14","current":-71.048454,"twenty":-63.220056,"median":-48.609184,"eighty":-41.232055,"marketCap":36368156956},{"date":"2024-06-21","current":-75.38559,"twenty":-65.709636,"median":-48.654461,"eighty":-41.23344,"marketCap":38507460307},{"date":"2024-06-28","current":-72.361795,"twenty":-70.050704,"median":-48.790889,"eighty":-41.25919,"marketCap":36947551614},{"date":"2024-07-05","current":-71.32983,"twenty":-70.110492,"median":-48.913989,"eighty":-41.293743,"marketCap":36412725776},{"date":"2024-07-12","current":-64.338068,"twenty":-69.786991,"median":-49.290918,"eighty":-41.483815,"marketCap":32891789012},{"date":"2024-07-19","current":-64.816339,"twenty":-69.10708,"median":-50.290098,"eighty":-41.560643,"marketCap":33136917521},{"date":"2024-07-26","current":-64.836994,"twenty":-68.943217,"median":-50.396598,"eighty":-41.836002,"marketCap":33270623980},{"date":"2024-08-02","current":-67.177788,"twenty":-68.832021,"median":-50.583009,"eighty":-41.911922,"marketCap":34451697705},{"date":"2024-08-09","current":-67.337335,"twenty":-68.832021,"median":-50.91108,"eighty":-41.921641,"marketCap":34763679444},{"date":"2024-08-16","current":-69.468586,"twenty":-68.832021,"median":-51.098991,"eighty":-41.970061,"marketCap":35877899939},{"date":"2024-08-23","current":-143.952492,"twenty":-69.519081,"median":-51.282062,"eighty":-42.023931,"marketCap":36568716645},{"date":"2024-08-30","current":-142.905377,"twenty":-70.543671,"median":-51.775379,"eighty":-42.069838,"marketCap":36546432236},{"date":"2024-09-06","current":-147.713941,"twenty":-71.622574,"median":-52.451442,"eighty":-42.229208,"marketCap":37794359190},{"date":"2024-09-13","current":-159.71572,"twenty":-72.235174,"median":-53.058458,"eighty":-42.319371,"marketCap":40758185707},{"date":"2024-09-20","current":-153.295015,"twenty":-72.624329,"median":-53.663008,"eighty":-42.346401,"marketCap":39354267883},{"date":"2024-09-27","current":-152.378595,"twenty":-73.54444,"median":-54.299669,"eighty":-42.364187,"marketCap":39354267883},{"date":"2024-10-04","current":-188.785359,"twenty":-74.133327,"median":-54.381491,"eighty":-42.385888,"marketCap":48535444762},{"date":"2024-10-10","current":-168.292174,"twenty":-74.96999,"median":-54.488817,"eighty":-42.420555,"marketCap":42986626697},{"date":"2024-10-18","current":-169.261982,"twenty":-75.395206,"median":-54.742682,"eighty":-42.48514,"marketCap":43008911107},{"date":"2024-10-25","current":-173.131782,"twenty":-76.300948,"median":-55.181976,"eighty":-42.60999,"marketCap":43989425142},{"date":"2024-11-01","current":-155.135166,"twenty":-77.964709,"median":-55.298647,"eighty":-42.767052,"marketCap":39443405523},{"date":"2024-11-08","current":-154.553256,"twenty":-78.843611,"median":-55.532894,"eighty":-42.819467,"marketCap":38997717325},{"date":"2024-11-15","current":-143.716763,"twenty":-80.792913,"median":-56.569783,"eighty":-42.897746,"marketCap":35989321988},{"date":"2024-11-22","current":-149.571879,"twenty":-86.542136,"median":-57.071537,"eighty":-43.077872,"marketCap":37437808632},{"date":"2024-11-29","current":-163.214034,"twenty":-139.660525,"median":-57.926605,"eighty":-43.27892,"marketCap":40825038936},{"date":"2024-12-06","current":-164.492389,"twenty":-143.07608,"median":-58.601892,"eighty":-43.427612,"marketCap":41047883035},{"date":"2024-12-13","current":-167.859925,"twenty":-143.961595,"median":-59.46824,"eighty":-43.489321,"marketCap":41805552972},{"date":"2024-12-20","current":-160.518216,"twenty":-146.054141,"median":-61.493522,"eighty":-43.569737,"marketCap":39799956081},{"date":"2024-12-27","current":-154.616488,"twenty":-147.398806,"median":-62.556972,"eighty":-43.707223,"marketCap":38306900618},{"date":"2025-01-03","current":-146.467928,"twenty":-147.580179,"median":-62.909234,"eighty":-43.769457,"marketCap":36323588137},{"date":"2025-01-10","current":-149.189796,"twenty":-147.713941,"median":-63.270129,"eighty":-43.89543,"marketCap":36858413974},{"date":"2025-01-17","current":-146.545949,"twenty":-148.128618,"median":-63.821936,"eighty":-43.999852,"marketCap":36234450497},{"date":"2025-01-24","current":-151.096908,"twenty":-148.795989,"median":-64.223738,"eighty":-44.022873,"marketCap":37593799501},{"date":"2025-01-28","current":-144.751587,"twenty":-148.750633,"median":-64.3181,"eighty":-44.025895,"marketCap":36203787461},{"date":"2025-02-07","current":-162.755483,"twenty":-148.864023,"median":-64.816339,"eighty":-44.095348,"marketCap":40476425278},{"date":"2025-02-14","current":-166.856795,"twenty":-150.654332,"median":-65.202788,"eighty":-44.112421,"marketCap":41476404342},{"date":"2025-02-21","current":-194.414734,"twenty":-151.676932,"median":-65.382992,"eighty":-44.172115,"marketCap":48498984584},{"date":"2025-02-28","current":-211.14481,"twenty":-152.24965,"median":-65.712478,"eighty":-44.17615,"marketCap":52498900839},{"date":"2025-03-07","current":-225.41295,"twenty":-152.905086,"median":-66.309677,"eighty":-44.219461,"marketCap":56271549124},{"date":"2025-03-14","current":-227.151092,"twenty":-153.295015,"median":-66.812487,"eighty":-44.308071,"marketCap":56726085062},{"date":"2025-03-21","current":-236.708664,"twenty":-154.553256,"median":-67.337335,"eighty":-44.550078,"marketCap":59089671940},{"date":"2025-03-28","current":-231.805328,"twenty":-155.61149,"median":-67.803663,"eighty":-44.648429,"marketCap":66180441600},{"date":"2025-04-03","current":-246.46154,"twenty":-156.727441,"median":-67.952396,"eighty":-44.882152,"marketCap":70225812000},{"date":"2025-04-11","current":-242.489155,"twenty":-158.779779,"median":-68.515098,"eighty":-45.005591,"marketCap":68634936000},{"date":"2025-04-17","current":-228.611836,"twenty":-159.44307,"median":-68.80487,"eighty":-45.06217,"marketCap":64862287200}],"updateTime":1745219898814}}}